Name | Number of supported studies | Average coverage | |
---|---|---|---|
capillary endothelial cell | 5 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of CD300LG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 11988.89 | 455 / 459 | 35% | 1.91 | 388 / 1118 |
adipose | 100% | 12479.24 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 91% | 1678.03 | 783 / 861 | 0% | 0 | 0 / 0 |
muscle | 85% | 874.95 | 685 / 803 | 0% | 0 | 0 / 0 |
lung | 72% | 1200.42 | 417 / 578 | 7% | 0.22 | 83 / 1155 |
skin | 48% | 534.34 | 862 / 1809 | 15% | 0.40 | 73 / 472 |
thymus | 34% | 286.42 | 220 / 653 | 24% | 0.87 | 144 / 605 |
kidney | 17% | 102.91 | 15 / 89 | 32% | 1.33 | 285 / 901 |
uterus | 42% | 314.38 | 72 / 170 | 4% | 0.13 | 18 / 459 |
adrenal gland | 18% | 130.53 | 47 / 258 | 26% | 1.04 | 59 / 230 |
spleen | 32% | 177.76 | 77 / 241 | 0% | 0 | 0 / 0 |
esophagus | 31% | 231.67 | 442 / 1445 | 1% | 0.03 | 2 / 183 |
bladder | 24% | 175.24 | 5 / 21 | 5% | 0.10 | 24 / 504 |
blood vessel | 28% | 310.26 | 375 / 1335 | 0% | 0 | 0 / 0 |
stomach | 24% | 155.21 | 87 / 359 | 3% | 0.13 | 8 / 286 |
brain | 0% | 0 | 0 / 2642 | 23% | 0.83 | 162 / 705 |
prostate | 15% | 85.68 | 36 / 245 | 8% | 0.15 | 40 / 502 |
ovary | 18% | 122.98 | 32 / 180 | 5% | 0.11 | 20 / 430 |
intestine | 19% | 154.61 | 188 / 966 | 3% | 0.12 | 14 / 527 |
liver | 0% | 1.85 | 1 / 226 | 16% | 0.52 | 66 / 406 |
pancreas | 5% | 22.77 | 15 / 328 | 12% | 0.30 | 21 / 178 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
peripheral blood | 0% | 1.38 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002376 | Biological process | immune system process |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CD300LG |
Protein name | CD300 molecule like family member g CMRF35-like molecule 9 (CLM-9) (CD300 antigen-like family member G) (Triggering receptor expressed on myeloid cells 4) (TREM-4) (CD antigen CD300g) |
Synonyms | CLM9 TREM4 UNQ422/PRO846 |
Description | FUNCTION: Receptor which may mediate L-selectin-dependent lymphocyte rollings. Binds SELL in a calcium dependent manner. Binds lymphocyte (By similarity). . |
Accessions | ENST00000586233.5 [Q6UXG3-3] ENST00000293396.12 [Q6UXG3-2] ENST00000317310.5 [Q6UXG3-1] ENST00000539718.5 [Q6UXG3-4] ENST00000700726.1 K7EL06 A0A8V8TQK5 ENST00000588884.1 ENST00000377203.8 [Q6UXG3-5] Q6UXG3 |